Global Adeno Associated Virus Aav Gene Therapy Market Research Report 2025(Status and Outlook)
The global Adeno Associated Virus Aav Gene Therapy market size was estimated at USD 1919.78 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.80% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Adeno Associated Virus Aav Gene Therapy market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Adeno Associated Virus Aav Gene Therapy market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Adeno Associated Virus Aav Gene Therapy market.
Global Adeno Associated Virus Aav Gene Therapy Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Creative Biolabs
Affinia Therapeutics
Spark Therapeutics
AGC Biologics
StrideBio
SIRION Biotech
Neurophth Biotechnology
Belief BioMed
BiBo Biopharma Engineering Co., LTD.
Beihai Kangcheng
PackGene Biotech
Sarepta Therapeutics
Carbon BioSciences
Kelonia Therapeutics
Roche
Remedium Bio
Market Segmentation (by Type)
Luxturna
Zolgensma
Others
Market Segmentation (by Application)
Central Nervous System Diseases
Ocular Diseases
Liver-directed Diseases
Other Hereditary Diseases
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Adeno Associated Virus Aav Gene Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Adeno Associated Virus Aav Gene Therapy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
This report offers a comprehensive and in-depth analysis of the global Adeno Associated Virus Aav Gene Therapy market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Adeno Associated Virus Aav Gene Therapy market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Adeno Associated Virus Aav Gene Therapy market.
Global Adeno Associated Virus Aav Gene Therapy Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Creative Biolabs
Affinia Therapeutics
Spark Therapeutics
AGC Biologics
StrideBio
SIRION Biotech
Neurophth Biotechnology
Belief BioMed
BiBo Biopharma Engineering Co., LTD.
Beihai Kangcheng
PackGene Biotech
Sarepta Therapeutics
Carbon BioSciences
Kelonia Therapeutics
Roche
Remedium Bio
Market Segmentation (by Type)
Luxturna
Zolgensma
Others
Market Segmentation (by Application)
Central Nervous System Diseases
Ocular Diseases
Liver-directed Diseases
Other Hereditary Diseases
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Adeno Associated Virus Aav Gene Therapy Market
- Overview of the regional outlook of the Adeno Associated Virus Aav Gene Therapy Market:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Adeno Associated Virus Aav Gene Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Adeno Associated Virus Aav Gene Therapy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Adeno Associated Virus Aav Gene Therapy
1.2 Key Market Segments
1.2.1 Adeno Associated Virus Aav Gene Therapy Segment by Type
1.2.2 Adeno Associated Virus Aav Gene Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ADENO ASSOCIATED VIRUS AAV GENE THERAPY MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ADENO ASSOCIATED VIRUS AAV GENE THERAPY MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Adeno Associated Virus Aav Gene Therapy Product Life Cycle
3.3 Global Adeno Associated Virus Aav Gene Therapy Revenue Market Share by Company (2020-2025)
3.4 Adeno Associated Virus Aav Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Adeno Associated Virus Aav Gene Therapy Company Headquarters, Area Served, Product Type
3.6 Adeno Associated Virus Aav Gene Therapy Market Competitive Situation and Trends
3.6.1 Adeno Associated Virus Aav Gene Therapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Adeno Associated Virus Aav Gene Therapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ADENO ASSOCIATED VIRUS AAV GENE THERAPY VALUE CHAIN ANALYSIS
4.1 Adeno Associated Virus Aav Gene Therapy Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ADENO ASSOCIATED VIRUS AAV GENE THERAPY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Adeno Associated Virus Aav Gene Therapy Market Porter's Five Forces Analysis
6 ADENO ASSOCIATED VIRUS AAV GENE THERAPY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Adeno Associated Virus Aav Gene Therapy Market Size Market Share by Type (2020-2025)
6.3 Global Adeno Associated Virus Aav Gene Therapy Market Size Growth Rate by Type (2021-2025)
7 ADENO ASSOCIATED VIRUS AAV GENE THERAPY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Adeno Associated Virus Aav Gene Therapy Market Size (M USD) by Application (2020-2025)
7.3 Global Adeno Associated Virus Aav Gene Therapy Sales Growth Rate by Application (2020-2025)
8 ADENO ASSOCIATED VIRUS AAV GENE THERAPY MARKET SEGMENTATION BY REGION
8.1 Global Adeno Associated Virus Aav Gene Therapy Market Size by Region
8.1.1 Global Adeno Associated Virus Aav Gene Therapy Market Size by Region
8.1.2 Global Adeno Associated Virus Aav Gene Therapy Market Size Market Share by Region
8.2 North America
8.2.1 North America Adeno Associated Virus Aav Gene Therapy Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Adeno Associated Virus Aav Gene Therapy Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Spain
8.4 Asia Pacific
8.4.1 Asia Pacific Adeno Associated Virus Aav Gene Therapy Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Adeno Associated Virus Aav Gene Therapy Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Adeno Associated Virus Aav Gene Therapy Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Creative Biolabs
9.1.1 Creative Biolabs Basic Information
9.1.2 Creative Biolabs Adeno Associated Virus Aav Gene Therapy Product Overview
9.1.3 Creative Biolabs Adeno Associated Virus Aav Gene Therapy Product Market Performance
9.1.4 Creative Biolabs SWOT Analysis
9.1.5 Creative Biolabs Business Overview
9.1.6 Creative Biolabs Recent Developments
9.2 Affinia Therapeutics
9.2.1 Affinia Therapeutics Basic Information
9.2.2 Affinia Therapeutics Adeno Associated Virus Aav Gene Therapy Product Overview
9.2.3 Affinia Therapeutics Adeno Associated Virus Aav Gene Therapy Product Market Performance
9.2.4 Affinia Therapeutics SWOT Analysis
9.2.5 Affinia Therapeutics Business Overview
9.2.6 Affinia Therapeutics Recent Developments
9.3 Spark Therapeutics
9.3.1 Spark Therapeutics Basic Information
9.3.2 Spark Therapeutics Adeno Associated Virus Aav Gene Therapy Product Overview
9.3.3 Spark Therapeutics Adeno Associated Virus Aav Gene Therapy Product Market Performance
9.3.4 Spark Therapeutics SWOT Analysis
9.3.5 Spark Therapeutics Business Overview
9.3.6 Spark Therapeutics Recent Developments
9.4 AGC Biologics
9.4.1 AGC Biologics Basic Information
9.4.2 AGC Biologics Adeno Associated Virus Aav Gene Therapy Product Overview
9.4.3 AGC Biologics Adeno Associated Virus Aav Gene Therapy Product Market Performance
9.4.4 AGC Biologics Business Overview
9.4.5 AGC Biologics Recent Developments
9.5 StrideBio
9.5.1 StrideBio Basic Information
9.5.2 StrideBio Adeno Associated Virus Aav Gene Therapy Product Overview
9.5.3 StrideBio Adeno Associated Virus Aav Gene Therapy Product Market Performance
9.5.4 StrideBio Business Overview
9.5.5 StrideBio Recent Developments
9.6 SIRION Biotech
9.6.1 SIRION Biotech Basic Information
9.6.2 SIRION Biotech Adeno Associated Virus Aav Gene Therapy Product Overview
9.6.3 SIRION Biotech Adeno Associated Virus Aav Gene Therapy Product Market Performance
9.6.4 SIRION Biotech Business Overview
9.6.5 SIRION Biotech Recent Developments
9.7 Neurophth Biotechnology
9.7.1 Neurophth Biotechnology Basic Information
9.7.2 Neurophth Biotechnology Adeno Associated Virus Aav Gene Therapy Product Overview
9.7.3 Neurophth Biotechnology Adeno Associated Virus Aav Gene Therapy Product Market Performance
9.7.4 Neurophth Biotechnology Business Overview
9.7.5 Neurophth Biotechnology Recent Developments
9.8 Belief BioMed
9.8.1 Belief BioMed Basic Information
9.8.2 Belief BioMed Adeno Associated Virus Aav Gene Therapy Product Overview
9.8.3 Belief BioMed Adeno Associated Virus Aav Gene Therapy Product Market Performance
9.8.4 Belief BioMed Business Overview
9.8.5 Belief BioMed Recent Developments
9.9 BiBo Biopharma Engineering Co., LTD.
9.9.1 BiBo Biopharma Engineering Co., LTD. Basic Information
9.9.2 BiBo Biopharma Engineering Co., LTD. Adeno Associated Virus Aav Gene Therapy Product Overview
9.9.3 BiBo Biopharma Engineering Co., LTD. Adeno Associated Virus Aav Gene Therapy Product Market Performance
9.9.4 BiBo Biopharma Engineering Co., LTD. Business Overview
9.9.5 BiBo Biopharma Engineering Co., LTD. Recent Developments
9.10 Beihai Kangcheng
9.10.1 Beihai Kangcheng Basic Information
9.10.2 Beihai Kangcheng Adeno Associated Virus Aav Gene Therapy Product Overview
9.10.3 Beihai Kangcheng Adeno Associated Virus Aav Gene Therapy Product Market Performance
9.10.4 Beihai Kangcheng Business Overview
9.10.5 Beihai Kangcheng Recent Developments
9.11 PackGene Biotech
9.11.1 PackGene Biotech Basic Information
9.11.2 PackGene Biotech Adeno Associated Virus Aav Gene Therapy Product Overview
9.11.3 PackGene Biotech Adeno Associated Virus Aav Gene Therapy Product Market Performance
9.11.4 PackGene Biotech Business Overview
9.11.5 PackGene Biotech Recent Developments
9.12 Sarepta Therapeutics
9.12.1 Sarepta Therapeutics Basic Information
9.12.2 Sarepta Therapeutics Adeno Associated Virus Aav Gene Therapy Product Overview
9.12.3 Sarepta Therapeutics Adeno Associated Virus Aav Gene Therapy Product Market Performance
9.12.4 Sarepta Therapeutics Business Overview
9.12.5 Sarepta Therapeutics Recent Developments
9.13 Carbon BioSciences
9.13.1 Carbon BioSciences Basic Information
9.13.2 Carbon BioSciences Adeno Associated Virus Aav Gene Therapy Product Overview
9.13.3 Carbon BioSciences Adeno Associated Virus Aav Gene Therapy Product Market Performance
9.13.4 Carbon BioSciences Business Overview
9.13.5 Carbon BioSciences Recent Developments
9.14 Kelonia Therapeutics
9.14.1 Kelonia Therapeutics Basic Information
9.14.2 Kelonia Therapeutics Adeno Associated Virus Aav Gene Therapy Product Overview
9.14.3 Kelonia Therapeutics Adeno Associated Virus Aav Gene Therapy Product Market Performance
9.14.4 Kelonia Therapeutics Business Overview
9.14.5 Kelonia Therapeutics Recent Developments
9.15 Roche
9.15.1 Roche Basic Information
9.15.2 Roche Adeno Associated Virus Aav Gene Therapy Product Overview
9.15.3 Roche Adeno Associated Virus Aav Gene Therapy Product Market Performance
9.15.4 Roche Business Overview
9.15.5 Roche Recent Developments
9.16 Remedium Bio
9.16.1 Remedium Bio Basic Information
9.16.2 Remedium Bio Adeno Associated Virus Aav Gene Therapy Product Overview
9.16.3 Remedium Bio Adeno Associated Virus Aav Gene Therapy Product Market Performance
9.16.4 Remedium Bio Business Overview
9.16.5 Remedium Bio Recent Developments
10 ADENO ASSOCIATED VIRUS AAV GENE THERAPY MARKET FORECAST BY REGION
10.1 Global Adeno Associated Virus Aav Gene Therapy Market Size Forecast
10.2 Global Adeno Associated Virus Aav Gene Therapy Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Adeno Associated Virus Aav Gene Therapy Market Size Forecast by Country
10.2.3 Asia Pacific Adeno Associated Virus Aav Gene Therapy Market Size Forecast by Region
10.2.4 South America Adeno Associated Virus Aav Gene Therapy Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Sales of Adeno Associated Virus Aav Gene Therapy by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
11.1 Global Adeno Associated Virus Aav Gene Therapy Market Forecast by Type (2026-2033)
11.2 Global Adeno Associated Virus Aav Gene Therapy Market Forecast by Application (2026-2033)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Adeno Associated Virus Aav Gene Therapy
1.2 Key Market Segments
1.2.1 Adeno Associated Virus Aav Gene Therapy Segment by Type
1.2.2 Adeno Associated Virus Aav Gene Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ADENO ASSOCIATED VIRUS AAV GENE THERAPY MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ADENO ASSOCIATED VIRUS AAV GENE THERAPY MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Adeno Associated Virus Aav Gene Therapy Product Life Cycle
3.3 Global Adeno Associated Virus Aav Gene Therapy Revenue Market Share by Company (2020-2025)
3.4 Adeno Associated Virus Aav Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Adeno Associated Virus Aav Gene Therapy Company Headquarters, Area Served, Product Type
3.6 Adeno Associated Virus Aav Gene Therapy Market Competitive Situation and Trends
3.6.1 Adeno Associated Virus Aav Gene Therapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Adeno Associated Virus Aav Gene Therapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ADENO ASSOCIATED VIRUS AAV GENE THERAPY VALUE CHAIN ANALYSIS
4.1 Adeno Associated Virus Aav Gene Therapy Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ADENO ASSOCIATED VIRUS AAV GENE THERAPY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Adeno Associated Virus Aav Gene Therapy Market Porter's Five Forces Analysis
6 ADENO ASSOCIATED VIRUS AAV GENE THERAPY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Adeno Associated Virus Aav Gene Therapy Market Size Market Share by Type (2020-2025)
6.3 Global Adeno Associated Virus Aav Gene Therapy Market Size Growth Rate by Type (2021-2025)
7 ADENO ASSOCIATED VIRUS AAV GENE THERAPY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Adeno Associated Virus Aav Gene Therapy Market Size (M USD) by Application (2020-2025)
7.3 Global Adeno Associated Virus Aav Gene Therapy Sales Growth Rate by Application (2020-2025)
8 ADENO ASSOCIATED VIRUS AAV GENE THERAPY MARKET SEGMENTATION BY REGION
8.1 Global Adeno Associated Virus Aav Gene Therapy Market Size by Region
8.1.1 Global Adeno Associated Virus Aav Gene Therapy Market Size by Region
8.1.2 Global Adeno Associated Virus Aav Gene Therapy Market Size Market Share by Region
8.2 North America
8.2.1 North America Adeno Associated Virus Aav Gene Therapy Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Adeno Associated Virus Aav Gene Therapy Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Spain
8.4 Asia Pacific
8.4.1 Asia Pacific Adeno Associated Virus Aav Gene Therapy Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Adeno Associated Virus Aav Gene Therapy Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Adeno Associated Virus Aav Gene Therapy Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Creative Biolabs
9.1.1 Creative Biolabs Basic Information
9.1.2 Creative Biolabs Adeno Associated Virus Aav Gene Therapy Product Overview
9.1.3 Creative Biolabs Adeno Associated Virus Aav Gene Therapy Product Market Performance
9.1.4 Creative Biolabs SWOT Analysis
9.1.5 Creative Biolabs Business Overview
9.1.6 Creative Biolabs Recent Developments
9.2 Affinia Therapeutics
9.2.1 Affinia Therapeutics Basic Information
9.2.2 Affinia Therapeutics Adeno Associated Virus Aav Gene Therapy Product Overview
9.2.3 Affinia Therapeutics Adeno Associated Virus Aav Gene Therapy Product Market Performance
9.2.4 Affinia Therapeutics SWOT Analysis
9.2.5 Affinia Therapeutics Business Overview
9.2.6 Affinia Therapeutics Recent Developments
9.3 Spark Therapeutics
9.3.1 Spark Therapeutics Basic Information
9.3.2 Spark Therapeutics Adeno Associated Virus Aav Gene Therapy Product Overview
9.3.3 Spark Therapeutics Adeno Associated Virus Aav Gene Therapy Product Market Performance
9.3.4 Spark Therapeutics SWOT Analysis
9.3.5 Spark Therapeutics Business Overview
9.3.6 Spark Therapeutics Recent Developments
9.4 AGC Biologics
9.4.1 AGC Biologics Basic Information
9.4.2 AGC Biologics Adeno Associated Virus Aav Gene Therapy Product Overview
9.4.3 AGC Biologics Adeno Associated Virus Aav Gene Therapy Product Market Performance
9.4.4 AGC Biologics Business Overview
9.4.5 AGC Biologics Recent Developments
9.5 StrideBio
9.5.1 StrideBio Basic Information
9.5.2 StrideBio Adeno Associated Virus Aav Gene Therapy Product Overview
9.5.3 StrideBio Adeno Associated Virus Aav Gene Therapy Product Market Performance
9.5.4 StrideBio Business Overview
9.5.5 StrideBio Recent Developments
9.6 SIRION Biotech
9.6.1 SIRION Biotech Basic Information
9.6.2 SIRION Biotech Adeno Associated Virus Aav Gene Therapy Product Overview
9.6.3 SIRION Biotech Adeno Associated Virus Aav Gene Therapy Product Market Performance
9.6.4 SIRION Biotech Business Overview
9.6.5 SIRION Biotech Recent Developments
9.7 Neurophth Biotechnology
9.7.1 Neurophth Biotechnology Basic Information
9.7.2 Neurophth Biotechnology Adeno Associated Virus Aav Gene Therapy Product Overview
9.7.3 Neurophth Biotechnology Adeno Associated Virus Aav Gene Therapy Product Market Performance
9.7.4 Neurophth Biotechnology Business Overview
9.7.5 Neurophth Biotechnology Recent Developments
9.8 Belief BioMed
9.8.1 Belief BioMed Basic Information
9.8.2 Belief BioMed Adeno Associated Virus Aav Gene Therapy Product Overview
9.8.3 Belief BioMed Adeno Associated Virus Aav Gene Therapy Product Market Performance
9.8.4 Belief BioMed Business Overview
9.8.5 Belief BioMed Recent Developments
9.9 BiBo Biopharma Engineering Co., LTD.
9.9.1 BiBo Biopharma Engineering Co., LTD. Basic Information
9.9.2 BiBo Biopharma Engineering Co., LTD. Adeno Associated Virus Aav Gene Therapy Product Overview
9.9.3 BiBo Biopharma Engineering Co., LTD. Adeno Associated Virus Aav Gene Therapy Product Market Performance
9.9.4 BiBo Biopharma Engineering Co., LTD. Business Overview
9.9.5 BiBo Biopharma Engineering Co., LTD. Recent Developments
9.10 Beihai Kangcheng
9.10.1 Beihai Kangcheng Basic Information
9.10.2 Beihai Kangcheng Adeno Associated Virus Aav Gene Therapy Product Overview
9.10.3 Beihai Kangcheng Adeno Associated Virus Aav Gene Therapy Product Market Performance
9.10.4 Beihai Kangcheng Business Overview
9.10.5 Beihai Kangcheng Recent Developments
9.11 PackGene Biotech
9.11.1 PackGene Biotech Basic Information
9.11.2 PackGene Biotech Adeno Associated Virus Aav Gene Therapy Product Overview
9.11.3 PackGene Biotech Adeno Associated Virus Aav Gene Therapy Product Market Performance
9.11.4 PackGene Biotech Business Overview
9.11.5 PackGene Biotech Recent Developments
9.12 Sarepta Therapeutics
9.12.1 Sarepta Therapeutics Basic Information
9.12.2 Sarepta Therapeutics Adeno Associated Virus Aav Gene Therapy Product Overview
9.12.3 Sarepta Therapeutics Adeno Associated Virus Aav Gene Therapy Product Market Performance
9.12.4 Sarepta Therapeutics Business Overview
9.12.5 Sarepta Therapeutics Recent Developments
9.13 Carbon BioSciences
9.13.1 Carbon BioSciences Basic Information
9.13.2 Carbon BioSciences Adeno Associated Virus Aav Gene Therapy Product Overview
9.13.3 Carbon BioSciences Adeno Associated Virus Aav Gene Therapy Product Market Performance
9.13.4 Carbon BioSciences Business Overview
9.13.5 Carbon BioSciences Recent Developments
9.14 Kelonia Therapeutics
9.14.1 Kelonia Therapeutics Basic Information
9.14.2 Kelonia Therapeutics Adeno Associated Virus Aav Gene Therapy Product Overview
9.14.3 Kelonia Therapeutics Adeno Associated Virus Aav Gene Therapy Product Market Performance
9.14.4 Kelonia Therapeutics Business Overview
9.14.5 Kelonia Therapeutics Recent Developments
9.15 Roche
9.15.1 Roche Basic Information
9.15.2 Roche Adeno Associated Virus Aav Gene Therapy Product Overview
9.15.3 Roche Adeno Associated Virus Aav Gene Therapy Product Market Performance
9.15.4 Roche Business Overview
9.15.5 Roche Recent Developments
9.16 Remedium Bio
9.16.1 Remedium Bio Basic Information
9.16.2 Remedium Bio Adeno Associated Virus Aav Gene Therapy Product Overview
9.16.3 Remedium Bio Adeno Associated Virus Aav Gene Therapy Product Market Performance
9.16.4 Remedium Bio Business Overview
9.16.5 Remedium Bio Recent Developments
10 ADENO ASSOCIATED VIRUS AAV GENE THERAPY MARKET FORECAST BY REGION
10.1 Global Adeno Associated Virus Aav Gene Therapy Market Size Forecast
10.2 Global Adeno Associated Virus Aav Gene Therapy Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Adeno Associated Virus Aav Gene Therapy Market Size Forecast by Country
10.2.3 Asia Pacific Adeno Associated Virus Aav Gene Therapy Market Size Forecast by Region
10.2.4 South America Adeno Associated Virus Aav Gene Therapy Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Sales of Adeno Associated Virus Aav Gene Therapy by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
11.1 Global Adeno Associated Virus Aav Gene Therapy Market Forecast by Type (2026-2033)
11.2 Global Adeno Associated Virus Aav Gene Therapy Market Forecast by Application (2026-2033)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Adeno Associated Virus Aav Gene Therapy Market Size Comparison by Region (M USD)
Table 5. Global Adeno Associated Virus Aav Gene Therapy Revenue (M USD) by Company (2020-2025)
Table 6. Global Adeno Associated Virus Aav Gene Therapy Revenue Share by Company (2020-2025)
Table 7. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adeno Associated Virus Aav Gene Therapy as of 2024)
Table 8. Adeno Associated Virus Aav Gene Therapy Company Headquarters and Area Served
Table 9. Company Adeno Associated Virus Aav Gene Therapy Product Type
Table 10. Global Adeno Associated Virus Aav Gene Therapy Company Market Concentration Ratio (CR5 and HHI)
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. Midstream Market Analysis
Table 13. Downstream Customer Analysis
Table 14. Key Development Trends
Table 15. Driving Factors
Table 16. Adeno Associated Virus Aav Gene Therapy Market Challenges
Table 17. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 18. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 19. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 20. Global Adeno Associated Virus Aav Gene Therapy Market Size by Type (M USD)
Table 21. Global Adeno Associated Virus Aav Gene Therapy Market Size (M USD) by Type (2020-2025)
Table 22. Global Adeno Associated Virus Aav Gene Therapy Market Size Share by Type (2020-2025)
Table 23. Global Adeno Associated Virus Aav Gene Therapy Market Size Growth Rate by Type (2021-2025)
Table 24. Global Adeno Associated Virus Aav Gene Therapy Market Size by Application
Table 25. Global Adeno Associated Virus Aav Gene Therapy Market Size by Application (2020-2025) & (M USD)
Table 26. Global Adeno Associated Virus Aav Gene Therapy Market Share by Application (2020-2025)
Table 27. Global Adeno Associated Virus Aav Gene Therapy Sales Growth Rate by Application (2020-2025)
Table 28. Global Adeno Associated Virus Aav Gene Therapy Market Size by Region (2020-2025) & (M USD)
Table 29. Global Adeno Associated Virus Aav Gene Therapy Market Size Market Share by Region (2020-2025)
Table 30. North America Adeno Associated Virus Aav Gene Therapy Market Size by Country (2020-2025) & (M USD)
Table 31. Europe Adeno Associated Virus Aav Gene Therapy Market Size by Country (2020-2025) & (M USD)
Table 32. Asia Pacific Adeno Associated Virus Aav Gene Therapy Market Size by Region (2020-2025) & (M USD)
Table 33. South America Adeno Associated Virus Aav Gene Therapy Market Size by Country (2020-2025) & (M USD)
Table 34. Middle East and Africa Adeno Associated Virus Aav Gene Therapy Market Size by Region (2020-2025) & (M USD)
Table 35. Creative Biolabs Basic Information
Table 36. Creative Biolabs Adeno Associated Virus Aav Gene Therapy Product Overview
Table 37. Creative Biolabs Adeno Associated Virus Aav Gene Therapy Revenue (M USD) and Gross Margin (2020-2025)
Table 38. Creative Biolabs SWOT Analysis
Table 39. Creative Biolabs Business Overview
Table 40. Creative Biolabs Recent Developments
Table 41. Affinia Therapeutics Basic Information
Table 42. Affinia Therapeutics Adeno Associated Virus Aav Gene Therapy Product Overview
Table 43. Affinia Therapeutics Adeno Associated Virus Aav Gene Therapy Revenue (M USD) and Gross Margin (2020-2025)
Table 44. Affinia Therapeutics SWOT Analysis
Table 45. Affinia Therapeutics Business Overview
Table 46. Affinia Therapeutics Recent Developments
Table 47. Spark Therapeutics Basic Information
Table 48. Spark Therapeutics Adeno Associated Virus Aav Gene Therapy Product Overview
Table 49. Spark Therapeutics Adeno Associated Virus Aav Gene Therapy Revenue (M USD) and Gross Margin (2020-2025)
Table 50. Spark Therapeutics SWOT Analysis
Table 51. Spark Therapeutics Business Overview
Table 52. Spark Therapeutics Recent Developments
Table 53. AGC Biologics Basic Information
Table 54. AGC Biologics Adeno Associated Virus Aav Gene Therapy Product Overview
Table 55. AGC Biologics Adeno Associated Virus Aav Gene Therapy Revenue (M USD) and Gross Margin (2020-2025)
Table 56. AGC Biologics Business Overview
Table 57. AGC Biologics Recent Developments
Table 58. StrideBio Basic Information
Table 59. StrideBio Adeno Associated Virus Aav Gene Therapy Product Overview
Table 60. StrideBio Adeno Associated Virus Aav Gene Therapy Revenue (M USD) and Gross Margin (2020-2025)
Table 61. StrideBio Business Overview
Table 62. StrideBio Recent Developments
Table 63. SIRION Biotech Basic Information
Table 64. SIRION Biotech Adeno Associated Virus Aav Gene Therapy Product Overview
Table 65. SIRION Biotech Adeno Associated Virus Aav Gene Therapy Revenue (M USD) and Gross Margin (2020-2025)
Table 66. SIRION Biotech Business Overview
Table 67. SIRION Biotech Recent Developments
Table 68. Neurophth Biotechnology Basic Information
Table 69. Neurophth Biotechnology Adeno Associated Virus Aav Gene Therapy Product Overview
Table 70. Neurophth Biotechnology Adeno Associated Virus Aav Gene Therapy Revenue (M USD) and Gross Margin (2020-2025)
Table 71. Neurophth Biotechnology Business Overview
Table 72. Neurophth Biotechnology Recent Developments
Table 73. Belief BioMed Basic Information
Table 74. Belief BioMed Adeno Associated Virus Aav Gene Therapy Product Overview
Table 75. Belief BioMed Adeno Associated Virus Aav Gene Therapy Revenue (M USD) and Gross Margin (2020-2025)
Table 76. Belief BioMed Business Overview
Table 77. Belief BioMed Recent Developments
Table 78. BiBo Biopharma Engineering Co., LTD. Basic Information
Table 79. BiBo Biopharma Engineering Co., LTD. Adeno Associated Virus Aav Gene Therapy Product Overview
Table 80. BiBo Biopharma Engineering Co., LTD. Adeno Associated Virus Aav Gene Therapy Revenue (M USD) and Gross Margin (2020-2025)
Table 81. BiBo Biopharma Engineering Co., LTD. Business Overview
Table 82. BiBo Biopharma Engineering Co., LTD. Recent Developments
Table 83. Beihai Kangcheng Basic Information
Table 84. Beihai Kangcheng Adeno Associated Virus Aav Gene Therapy Product Overview
Table 85. Beihai Kangcheng Adeno Associated Virus Aav Gene Therapy Revenue (M USD) and Gross Margin (2020-2025)
Table 86. Beihai Kangcheng Business Overview
Table 87. Beihai Kangcheng Recent Developments
Table 88. PackGene Biotech Basic Information
Table 89. PackGene Biotech Adeno Associated Virus Aav Gene Therapy Product Overview
Table 90. PackGene Biotech Adeno Associated Virus Aav Gene Therapy Revenue (M USD) and Gross Margin (2020-2025)
Table 91. PackGene Biotech Business Overview
Table 92. PackGene Biotech Recent Developments
Table 93. Sarepta Therapeutics Basic Information
Table 94. Sarepta Therapeutics Adeno Associated Virus Aav Gene Therapy Product Overview
Table 95. Sarepta Therapeutics Adeno Associated Virus Aav Gene Therapy Revenue (M USD) and Gross Margin (2020-2025)
Table 96. Sarepta Therapeutics Business Overview
Table 97. Sarepta Therapeutics Recent Developments
Table 98. Carbon BioSciences Basic Information
Table 99. Carbon BioSciences Adeno Associated Virus Aav Gene Therapy Product Overview
Table 100. Carbon BioSciences Adeno Associated Virus Aav Gene Therapy Revenue (M USD) and Gross Margin (2020-2025)
Table 101. Carbon BioSciences Business Overview
Table 102. Carbon BioSciences Recent Developments
Table 103. Kelonia Therapeutics Basic Information
Table 104. Kelonia Therapeutics Adeno Associated Virus Aav Gene Therapy Product Overview
Table 105. Kelonia Therapeutics Adeno Associated Virus Aav Gene Therapy Revenue (M USD) and Gross Margin (2020-2025)
Table 106. Kelonia Therapeutics Business Overview
Table 107. Kelonia Therapeutics Recent Developments
Table 108. Roche Basic Information
Table 109. Roche Adeno Associated Virus Aav Gene Therapy Product Overview
Table 110. Roche Adeno Associated Virus Aav Gene Therapy Revenue (M USD) and Gross Margin (2020-2025)
Table 111. Roche Business Overview
Table 112. Roche Recent Developments
Table 113. Remedium Bio Basic Information
Table 114. Remedium Bio Adeno Associated Virus Aav Gene Therapy Product Overview
Table 115. Remedium Bio Adeno Associated Virus Aav Gene Therapy Revenue (M USD) and Gross Margin (2020-2025)
Table 116. Remedium Bio Business Overview
Table 117. Remedium Bio Recent Developments
Table 118. Global Adeno Associated Virus Aav Gene Therapy Market Size Forecast by Region (2026-2033) & (M USD)
Table 119. North America Adeno Associated Virus Aav Gene Therapy Market Size Forecast by Country (2026-2033) & (M USD)
Table 120. Europe Adeno Associated Virus Aav Gene Therapy Market Size Forecast by Country (2026-2033) & (M USD)
Table 121. Asia Pacific Adeno Associated Virus Aav Gene Therapy Market Size Forecast by Region (2026-2033) & (M USD)
Table 122. South America Adeno Associated Virus Aav Gene Therapy Market Size Forecast by Country (2026-2033) & (M USD)
Table 123. Middle East and Africa Adeno Associated Virus Aav Gene Therapy Market Size Forecast by Country (2026-2033) & (M USD)
Table 124. Global Adeno Associated Virus Aav Gene Therapy Market Size Forecast by Type (2026-2033) & (M USD)
Table 125. Global Adeno Associated Virus Aav Gene Therapy Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Adeno Associated Virus Aav Gene Therapy Market Size Comparison by Region (M USD)
Table 5. Global Adeno Associated Virus Aav Gene Therapy Revenue (M USD) by Company (2020-2025)
Table 6. Global Adeno Associated Virus Aav Gene Therapy Revenue Share by Company (2020-2025)
Table 7. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adeno Associated Virus Aav Gene Therapy as of 2024)
Table 8. Adeno Associated Virus Aav Gene Therapy Company Headquarters and Area Served
Table 9. Company Adeno Associated Virus Aav Gene Therapy Product Type
Table 10. Global Adeno Associated Virus Aav Gene Therapy Company Market Concentration Ratio (CR5 and HHI)
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. Midstream Market Analysis
Table 13. Downstream Customer Analysis
Table 14. Key Development Trends
Table 15. Driving Factors
Table 16. Adeno Associated Virus Aav Gene Therapy Market Challenges
Table 17. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 18. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 19. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 20. Global Adeno Associated Virus Aav Gene Therapy Market Size by Type (M USD)
Table 21. Global Adeno Associated Virus Aav Gene Therapy Market Size (M USD) by Type (2020-2025)
Table 22. Global Adeno Associated Virus Aav Gene Therapy Market Size Share by Type (2020-2025)
Table 23. Global Adeno Associated Virus Aav Gene Therapy Market Size Growth Rate by Type (2021-2025)
Table 24. Global Adeno Associated Virus Aav Gene Therapy Market Size by Application
Table 25. Global Adeno Associated Virus Aav Gene Therapy Market Size by Application (2020-2025) & (M USD)
Table 26. Global Adeno Associated Virus Aav Gene Therapy Market Share by Application (2020-2025)
Table 27. Global Adeno Associated Virus Aav Gene Therapy Sales Growth Rate by Application (2020-2025)
Table 28. Global Adeno Associated Virus Aav Gene Therapy Market Size by Region (2020-2025) & (M USD)
Table 29. Global Adeno Associated Virus Aav Gene Therapy Market Size Market Share by Region (2020-2025)
Table 30. North America Adeno Associated Virus Aav Gene Therapy Market Size by Country (2020-2025) & (M USD)
Table 31. Europe Adeno Associated Virus Aav Gene Therapy Market Size by Country (2020-2025) & (M USD)
Table 32. Asia Pacific Adeno Associated Virus Aav Gene Therapy Market Size by Region (2020-2025) & (M USD)
Table 33. South America Adeno Associated Virus Aav Gene Therapy Market Size by Country (2020-2025) & (M USD)
Table 34. Middle East and Africa Adeno Associated Virus Aav Gene Therapy Market Size by Region (2020-2025) & (M USD)
Table 35. Creative Biolabs Basic Information
Table 36. Creative Biolabs Adeno Associated Virus Aav Gene Therapy Product Overview
Table 37. Creative Biolabs Adeno Associated Virus Aav Gene Therapy Revenue (M USD) and Gross Margin (2020-2025)
Table 38. Creative Biolabs SWOT Analysis
Table 39. Creative Biolabs Business Overview
Table 40. Creative Biolabs Recent Developments
Table 41. Affinia Therapeutics Basic Information
Table 42. Affinia Therapeutics Adeno Associated Virus Aav Gene Therapy Product Overview
Table 43. Affinia Therapeutics Adeno Associated Virus Aav Gene Therapy Revenue (M USD) and Gross Margin (2020-2025)
Table 44. Affinia Therapeutics SWOT Analysis
Table 45. Affinia Therapeutics Business Overview
Table 46. Affinia Therapeutics Recent Developments
Table 47. Spark Therapeutics Basic Information
Table 48. Spark Therapeutics Adeno Associated Virus Aav Gene Therapy Product Overview
Table 49. Spark Therapeutics Adeno Associated Virus Aav Gene Therapy Revenue (M USD) and Gross Margin (2020-2025)
Table 50. Spark Therapeutics SWOT Analysis
Table 51. Spark Therapeutics Business Overview
Table 52. Spark Therapeutics Recent Developments
Table 53. AGC Biologics Basic Information
Table 54. AGC Biologics Adeno Associated Virus Aav Gene Therapy Product Overview
Table 55. AGC Biologics Adeno Associated Virus Aav Gene Therapy Revenue (M USD) and Gross Margin (2020-2025)
Table 56. AGC Biologics Business Overview
Table 57. AGC Biologics Recent Developments
Table 58. StrideBio Basic Information
Table 59. StrideBio Adeno Associated Virus Aav Gene Therapy Product Overview
Table 60. StrideBio Adeno Associated Virus Aav Gene Therapy Revenue (M USD) and Gross Margin (2020-2025)
Table 61. StrideBio Business Overview
Table 62. StrideBio Recent Developments
Table 63. SIRION Biotech Basic Information
Table 64. SIRION Biotech Adeno Associated Virus Aav Gene Therapy Product Overview
Table 65. SIRION Biotech Adeno Associated Virus Aav Gene Therapy Revenue (M USD) and Gross Margin (2020-2025)
Table 66. SIRION Biotech Business Overview
Table 67. SIRION Biotech Recent Developments
Table 68. Neurophth Biotechnology Basic Information
Table 69. Neurophth Biotechnology Adeno Associated Virus Aav Gene Therapy Product Overview
Table 70. Neurophth Biotechnology Adeno Associated Virus Aav Gene Therapy Revenue (M USD) and Gross Margin (2020-2025)
Table 71. Neurophth Biotechnology Business Overview
Table 72. Neurophth Biotechnology Recent Developments
Table 73. Belief BioMed Basic Information
Table 74. Belief BioMed Adeno Associated Virus Aav Gene Therapy Product Overview
Table 75. Belief BioMed Adeno Associated Virus Aav Gene Therapy Revenue (M USD) and Gross Margin (2020-2025)
Table 76. Belief BioMed Business Overview
Table 77. Belief BioMed Recent Developments
Table 78. BiBo Biopharma Engineering Co., LTD. Basic Information
Table 79. BiBo Biopharma Engineering Co., LTD. Adeno Associated Virus Aav Gene Therapy Product Overview
Table 80. BiBo Biopharma Engineering Co., LTD. Adeno Associated Virus Aav Gene Therapy Revenue (M USD) and Gross Margin (2020-2025)
Table 81. BiBo Biopharma Engineering Co., LTD. Business Overview
Table 82. BiBo Biopharma Engineering Co., LTD. Recent Developments
Table 83. Beihai Kangcheng Basic Information
Table 84. Beihai Kangcheng Adeno Associated Virus Aav Gene Therapy Product Overview
Table 85. Beihai Kangcheng Adeno Associated Virus Aav Gene Therapy Revenue (M USD) and Gross Margin (2020-2025)
Table 86. Beihai Kangcheng Business Overview
Table 87. Beihai Kangcheng Recent Developments
Table 88. PackGene Biotech Basic Information
Table 89. PackGene Biotech Adeno Associated Virus Aav Gene Therapy Product Overview
Table 90. PackGene Biotech Adeno Associated Virus Aav Gene Therapy Revenue (M USD) and Gross Margin (2020-2025)
Table 91. PackGene Biotech Business Overview
Table 92. PackGene Biotech Recent Developments
Table 93. Sarepta Therapeutics Basic Information
Table 94. Sarepta Therapeutics Adeno Associated Virus Aav Gene Therapy Product Overview
Table 95. Sarepta Therapeutics Adeno Associated Virus Aav Gene Therapy Revenue (M USD) and Gross Margin (2020-2025)
Table 96. Sarepta Therapeutics Business Overview
Table 97. Sarepta Therapeutics Recent Developments
Table 98. Carbon BioSciences Basic Information
Table 99. Carbon BioSciences Adeno Associated Virus Aav Gene Therapy Product Overview
Table 100. Carbon BioSciences Adeno Associated Virus Aav Gene Therapy Revenue (M USD) and Gross Margin (2020-2025)
Table 101. Carbon BioSciences Business Overview
Table 102. Carbon BioSciences Recent Developments
Table 103. Kelonia Therapeutics Basic Information
Table 104. Kelonia Therapeutics Adeno Associated Virus Aav Gene Therapy Product Overview
Table 105. Kelonia Therapeutics Adeno Associated Virus Aav Gene Therapy Revenue (M USD) and Gross Margin (2020-2025)
Table 106. Kelonia Therapeutics Business Overview
Table 107. Kelonia Therapeutics Recent Developments
Table 108. Roche Basic Information
Table 109. Roche Adeno Associated Virus Aav Gene Therapy Product Overview
Table 110. Roche Adeno Associated Virus Aav Gene Therapy Revenue (M USD) and Gross Margin (2020-2025)
Table 111. Roche Business Overview
Table 112. Roche Recent Developments
Table 113. Remedium Bio Basic Information
Table 114. Remedium Bio Adeno Associated Virus Aav Gene Therapy Product Overview
Table 115. Remedium Bio Adeno Associated Virus Aav Gene Therapy Revenue (M USD) and Gross Margin (2020-2025)
Table 116. Remedium Bio Business Overview
Table 117. Remedium Bio Recent Developments
Table 118. Global Adeno Associated Virus Aav Gene Therapy Market Size Forecast by Region (2026-2033) & (M USD)
Table 119. North America Adeno Associated Virus Aav Gene Therapy Market Size Forecast by Country (2026-2033) & (M USD)
Table 120. Europe Adeno Associated Virus Aav Gene Therapy Market Size Forecast by Country (2026-2033) & (M USD)
Table 121. Asia Pacific Adeno Associated Virus Aav Gene Therapy Market Size Forecast by Region (2026-2033) & (M USD)
Table 122. South America Adeno Associated Virus Aav Gene Therapy Market Size Forecast by Country (2026-2033) & (M USD)
Table 123. Middle East and Africa Adeno Associated Virus Aav Gene Therapy Market Size Forecast by Country (2026-2033) & (M USD)
Table 124. Global Adeno Associated Virus Aav Gene Therapy Market Size Forecast by Type (2026-2033) & (M USD)
Table 125. Global Adeno Associated Virus Aav Gene Therapy Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Industry Chain of Adeno Associated Virus Aav Gene Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Adeno Associated Virus Aav Gene Therapy Market Size (M USD), 2024-2033
Figure 5. Global Adeno Associated Virus Aav Gene Therapy Market Size (M USD) (2020-2033)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Adeno Associated Virus Aav Gene Therapy Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global Adeno Associated Virus Aav Gene Therapy Product Life Cycle
Figure 12. Global Adeno Associated Virus Aav Gene Therapy Revenue Share by Company in 2024
Figure 13. Adeno Associated Virus Aav Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 14. The Global 5 and 10 Largest Players: Market Share by Adeno Associated Virus Aav Gene Therapy Revenue in 2024
Figure 15. Value Chain Map of Adeno Associated Virus Aav Gene Therapy
Figure 16. Global Adeno Associated Virus Aav Gene Therapy Market PEST Analysis
Figure 17. Global Adeno Associated Virus Aav Gene Therapy Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global Adeno Associated Virus Aav Gene Therapy Market Share by Type
Figure 20. Market Size Share of Adeno Associated Virus Aav Gene Therapy by Type (2020-2025)
Figure 21. Market Size Share of Adeno Associated Virus Aav Gene Therapy by Type in 2024
Figure 22. Global Adeno Associated Virus Aav Gene Therapy Market Size Growth Rate by Type (2021-2025)
Figure 23. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 24. Global Adeno Associated Virus Aav Gene Therapy Market Share by Application
Figure 25. Global Adeno Associated Virus Aav Gene Therapy Market Share by Application (2020-2025)
Figure 26. Global Adeno Associated Virus Aav Gene Therapy Market Share by Application in 2024
Figure 27. Global Adeno Associated Virus Aav Gene Therapy Sales Growth Rate by Application (2020-2025)
Figure 28. Global Adeno Associated Virus Aav Gene Therapy Market Size Market Share by Region (2020-2025)
Figure 29. North America Adeno Associated Virus Aav Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 30. North America Adeno Associated Virus Aav Gene Therapy Market Size Market Share by Country in 2024
Figure 31. U.S. Adeno Associated Virus Aav Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 32. Canada Adeno Associated Virus Aav Gene Therapy Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Mexico Adeno Associated Virus Aav Gene Therapy Market Size (M USD) and Growth Rate (2020-2025)
Figure 34. Europe Adeno Associated Virus Aav Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 35. Europe Adeno Associated Virus Aav Gene Therapy Market Share by Country in 2024
Figure 36. Germany Adeno Associated Virus Aav Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. France Adeno Associated Virus Aav Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. U.K. Adeno Associated Virus Aav Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Italy Adeno Associated Virus Aav Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Spain Adeno Associated Virus Aav Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 41. Asia Pacific Adeno Associated Virus Aav Gene Therapy Market Size and Growth Rate (M USD)
Figure 42. Asia Pacific Adeno Associated Virus Aav Gene Therapy Market Size Market Share by Region in 2024
Figure 43. China Adeno Associated Virus Aav Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. Japan Adeno Associated Virus Aav Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. South Korea Adeno Associated Virus Aav Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. India Adeno Associated Virus Aav Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Southeast Asia Adeno Associated Virus Aav Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 48. South America Adeno Associated Virus Aav Gene Therapy Market Size and Growth Rate (M USD)
Figure 49. South America Adeno Associated Virus Aav Gene Therapy Market Size Market Share by Country in 2024
Figure 50. Brazil Adeno Associated Virus Aav Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Argentina Adeno Associated Virus Aav Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Columbia Adeno Associated Virus Aav Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 53. Middle East and Africa Adeno Associated Virus Aav Gene Therapy Market Size and Growth Rate (M USD)
Figure 54. Middle East and Africa Adeno Associated Virus Aav Gene Therapy Market Size Market Share by Region in 2024
Figure 55. Saudi Arabia Adeno Associated Virus Aav Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. UAE Adeno Associated Virus Aav Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Egypt Adeno Associated Virus Aav Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. Nigeria Adeno Associated Virus Aav Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. South Africa Adeno Associated Virus Aav Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Global Adeno Associated Virus Aav Gene Therapy Market Size Forecast (2020-2033) & (M USD)
Figure 61. Global Adeno Associated Virus Aav Gene Therapy Market Share Forecast by Type (2026-2033)
Figure 62. Global Adeno Associated Virus Aav Gene Therapy Market Share Forecast by Application (2026-2033)
Figure 1. Industry Chain of Adeno Associated Virus Aav Gene Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Adeno Associated Virus Aav Gene Therapy Market Size (M USD), 2024-2033
Figure 5. Global Adeno Associated Virus Aav Gene Therapy Market Size (M USD) (2020-2033)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Adeno Associated Virus Aav Gene Therapy Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global Adeno Associated Virus Aav Gene Therapy Product Life Cycle
Figure 12. Global Adeno Associated Virus Aav Gene Therapy Revenue Share by Company in 2024
Figure 13. Adeno Associated Virus Aav Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 14. The Global 5 and 10 Largest Players: Market Share by Adeno Associated Virus Aav Gene Therapy Revenue in 2024
Figure 15. Value Chain Map of Adeno Associated Virus Aav Gene Therapy
Figure 16. Global Adeno Associated Virus Aav Gene Therapy Market PEST Analysis
Figure 17. Global Adeno Associated Virus Aav Gene Therapy Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global Adeno Associated Virus Aav Gene Therapy Market Share by Type
Figure 20. Market Size Share of Adeno Associated Virus Aav Gene Therapy by Type (2020-2025)
Figure 21. Market Size Share of Adeno Associated Virus Aav Gene Therapy by Type in 2024
Figure 22. Global Adeno Associated Virus Aav Gene Therapy Market Size Growth Rate by Type (2021-2025)
Figure 23. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 24. Global Adeno Associated Virus Aav Gene Therapy Market Share by Application
Figure 25. Global Adeno Associated Virus Aav Gene Therapy Market Share by Application (2020-2025)
Figure 26. Global Adeno Associated Virus Aav Gene Therapy Market Share by Application in 2024
Figure 27. Global Adeno Associated Virus Aav Gene Therapy Sales Growth Rate by Application (2020-2025)
Figure 28. Global Adeno Associated Virus Aav Gene Therapy Market Size Market Share by Region (2020-2025)
Figure 29. North America Adeno Associated Virus Aav Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 30. North America Adeno Associated Virus Aav Gene Therapy Market Size Market Share by Country in 2024
Figure 31. U.S. Adeno Associated Virus Aav Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 32. Canada Adeno Associated Virus Aav Gene Therapy Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Mexico Adeno Associated Virus Aav Gene Therapy Market Size (M USD) and Growth Rate (2020-2025)
Figure 34. Europe Adeno Associated Virus Aav Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 35. Europe Adeno Associated Virus Aav Gene Therapy Market Share by Country in 2024
Figure 36. Germany Adeno Associated Virus Aav Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. France Adeno Associated Virus Aav Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. U.K. Adeno Associated Virus Aav Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Italy Adeno Associated Virus Aav Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Spain Adeno Associated Virus Aav Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 41. Asia Pacific Adeno Associated Virus Aav Gene Therapy Market Size and Growth Rate (M USD)
Figure 42. Asia Pacific Adeno Associated Virus Aav Gene Therapy Market Size Market Share by Region in 2024
Figure 43. China Adeno Associated Virus Aav Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. Japan Adeno Associated Virus Aav Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. South Korea Adeno Associated Virus Aav Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. India Adeno Associated Virus Aav Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Southeast Asia Adeno Associated Virus Aav Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 48. South America Adeno Associated Virus Aav Gene Therapy Market Size and Growth Rate (M USD)
Figure 49. South America Adeno Associated Virus Aav Gene Therapy Market Size Market Share by Country in 2024
Figure 50. Brazil Adeno Associated Virus Aav Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Argentina Adeno Associated Virus Aav Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Columbia Adeno Associated Virus Aav Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 53. Middle East and Africa Adeno Associated Virus Aav Gene Therapy Market Size and Growth Rate (M USD)
Figure 54. Middle East and Africa Adeno Associated Virus Aav Gene Therapy Market Size Market Share by Region in 2024
Figure 55. Saudi Arabia Adeno Associated Virus Aav Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. UAE Adeno Associated Virus Aav Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Egypt Adeno Associated Virus Aav Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. Nigeria Adeno Associated Virus Aav Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. South Africa Adeno Associated Virus Aav Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Global Adeno Associated Virus Aav Gene Therapy Market Size Forecast (2020-2033) & (M USD)
Figure 61. Global Adeno Associated Virus Aav Gene Therapy Market Share Forecast by Type (2026-2033)
Figure 62. Global Adeno Associated Virus Aav Gene Therapy Market Share Forecast by Application (2026-2033)
